The quantitative range and reproducibility of current serological tests for severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) are not optimized. Herein, we developed …

Background The COVID-19 pandemic necessitates better understanding of the kinetics of
antibody production induced by infection with SARS-CoV-2. We aimed to develop a high …

Background Knowledge of the COVID-19 epidemic extent and the level of herd immunity is
urgently needed to help manage this pandemic. Methods We used a panel of 167 samples …

Background The 2019 novel coronavirus disease (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 virus (SARS-CoV-2) is a current worldwide threat for …

Objectives The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has rapidly spread globally. The laboratory diagnosis of SARS-CoV-2 infection has relied on …

Background Serological tests for anti-SARS-CoV-2 antibodies are becoming of great interest
to determine seroprevalence in a given population, define previous exposure and identify …

Serology testing of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is
increasingly being used during the current pandemic of coronavirus disease 2019 (COVID …

The role of serologic testing for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), in both the clinical and public health settings, will continue to evolve as we gain …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent
of coronavirus disease 2019 (COVID-19). Molecular-based testing is used to diagnose …

There is an urgent need for an accurate antibody test for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). We have developed 3 ELISA methods, trimer spike IgA, trimer …